Gilde Healthcare Partners recruits new partners and opens new office in the US - Gilde Healthcare

Gilde Healthcare Partners recruits new partners and opens new office in the US

November 10, 2011

Utrecht, the Netherlands | Cambridge, USA – Gilde Healthcare Partners a €450 million ($600 million) venture and growth capital group based in Utrecht, Netherlands has announced the opening of its office in Cambridge, MA. The firm’s US investment activity is managed by Geoff Pardo who recently joined Gilde as Partner. Geoff has spent the last eleven years in a mix of venture capital and operating roles at Cardinal Partners, Spray Venture Partners and most recently as CEO of Facet Solutions, a spinal implant company that was sold to Globus Medical.  
In addition, Janke Dittmer joined Gilde Healthcare, in The Netherlands, as Partner. Janke has been senior director new business development and venture general manager at Philips Healthcare's corporate venturing unit. Prior to this he was a manager at McKinsey.

Earlier this week Gilde announced the first investment from Gilde Healthcare III in Inova Labs based in Austin, TX. Inova Labs has developed a novel, proprietary portable oxygen concentrator which allows for greater patient mobility for patients suffering from Chronic Obstructive Pulmonary Disease. The new round allows Inova to expand commercialization of its flagship product, LifeChO2ice.

About Gilde Healthcare Partners

Netherlands-based Gilde Healthcare Partners is a transatlantic venture and growth capital firm focused on private healthcare technology and service companies. It has over €450 million ($600 million) under management and is actively looking to lead new investments in therapeutics, diagnostics, medical devices and healthcare services. Gilde successfully builds healthcare businesses across Europe and US, investing up to €15 million ($20 million) in a single portfolio company. For a list of Gilde’s portfolio companies please visit the website at www.gildehealthcare.com.

Contact details

Gilde Healthcare Partners US Inc.
245 First Street, 18th floor
Cambridge, MA 02142
U.S.A.
Tel.: +1 617 395 9080

Gilde Healthcare Partners BV
Newtonlaan 91
3508 AB Utrecht
The Netherlands
Tel.: +31 30 219 2528

Gilde Healthcare company CatalYm announces leadership changes to accelerate visugromab late-stage clinical development

Gilde Healthcare company CatalYm, a world-leader in neutralizing GDF-15 in cancer and cachexia, today announced changes to its executive leadership team to support its next stage of growth. The appointments of Clinton Musil as Chief...
September 15, 2025

Gilde Healthcare company Tagworks Pharmaceuticals Announces Initiation of Third Dose Level in Ongoing Phase 1 Clinical Trial of TGW101 for the Treatment of Solid Tumors

TGW101 is a next-generation, first-in-class ADC targeting TAG-72 with an MMAE payload, developed based on Tagworks proprietary Click-to-Release linker chemistry; TGW101 is the first bioorthogonal, in vivo click chemistry-activated ADC, which enables superior control of tumor...
September 10, 2025

Gilde Healthcare appoints Dr. Christian Stark as Group CEO of its globally operating medical technology group

The medical technology group, which includes two manufacturers of surgical instruments in the Tuttlingen region, Koscher & Würtz and Christian Diener, has appointed Dr. Christian Stark as Chief Executive Officer (CEO) with effect from September...
September 3, 2025